Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Colloids Surf B Biointerfaces ; 175: 158-165, 2019 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-30530001

RESUMO

Magnesium (Mg) and strontium (Sr), which are essential nutrient elements in the natural bone, positively affect the osteogenic activity even in wide ranges of ion concentrations. However, it remains unknown whether magnesium-strontium phosphates [MgxSr3-x(PO4)2] are potential bone grafts for accelerating bone regeneration. Herein, a serial of MgxSr3-x(PO4)2, including Mg3(PO4)2, Mg2Sr(PO4)2, Mg1.5Sr1.5(PO4)2, MgSr2(PO4)2 and Sr3(PO4)2, were synthesized using a solid-state reaction approach. The physicochemical properties and cell behaviors of MgxSr3-x(PO4)2 bioceramics were characterized and compared with the common bone graft ß-tricalcium phosphate (ß-TCP). The results indicated that various MgxSr3-x(PO4)2 bioceramics differed in compressive strength and in vitro degradation rate. All the MgxSr3-x(PO4)2 bioceramics had excellent biocompatibility. In contrast to ß-TCP, the MgxSr3-x(PO4)2 enhanced alkaline phosphatase activity of mouse bone mesenchymal stem cells (mBMSCs), and inhibited osteoclastogenesis-related gene expression of RAW264.7 cells, but did not enhance osteogenesis-related gene expression of mBMSCs which were treated with osteogenesis induction supplements. However, Mg3(PO4)2 stimulated osteogenesis-related gene expression of mBMSCs without the treatment of osteogenesis induction supplements. This work contributes to the design of bone graft and may open a new avenue for the bone regeneration field.


Assuntos
Materiais Biocompatíveis/farmacologia , Cerâmica/farmacologia , Compostos de Magnésio/farmacologia , Fosfatos/farmacologia , Estrôncio/farmacologia , Animais , Materiais Biocompatíveis/síntese química , Materiais Biocompatíveis/química , Regeneração Óssea/efeitos dos fármacos , Regeneração Óssea/genética , Substitutos Ósseos/química , Transplante Ósseo/métodos , Osso e Ossos/citologia , Osso e Ossos/efeitos dos fármacos , Osso e Ossos/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/genética , Células Cultivadas , Cerâmica/síntese química , Cerâmica/química , Expressão Gênica/efeitos dos fármacos , Compostos de Magnésio/síntese química , Compostos de Magnésio/química , Células-Tronco Mesenquimais/efeitos dos fármacos , Células-Tronco Mesenquimais/metabolismo , Camundongos , Osteogênese/efeitos dos fármacos , Osteogênese/genética , Fosfatos/síntese química , Fosfatos/química , Células RAW 264.7 , Estrôncio/química
2.
Anal Bioanal Chem ; 407(12): 3525-9, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25736243

RESUMO

2,4-Difluoro-3-formyl-phenylboronic acid (DFFPBA)-modified magnetic attapulgite (ATP-Fe3O4-NH2-DFFPBA) was synthesized and employed to capture and enrich cis-diol-containing biomolecules. The resulting material exhibited a high saturation magnetization value of 20.71 emu/g, allowing the absorbent to be conveniently magnetically separated. Combining the Fe3O4 nanoparticles with the high specific surface area of attapulgite yielded a material with a high capture capacity (13.78 mg/g) for adenosine. Furthermore, ATP-Fe3O4-NH2-DFFPBA was found to possess remarkable selectivity for adenosine at a low molar ratio of adenosine/2-deoxyadenosine (1:500). The potential applications of this material were explored by using it to extract five nucleosides from urine samples, and the results demonstrate that it can decrease matrix interference and selectively enrich analytes.


Assuntos
Compostos de Magnésio/química , Nucleosídeos/química , Nucleosídeos/urina , Compostos de Silício/química , Urinálise/métodos , Adenosina/química , Adenosina/metabolismo , Ácidos Borônicos/química , Fracionamento Químico/métodos , Técnicas de Química Sintética , Humanos , Limite de Detecção , Compostos de Magnésio/síntese química , Compostos de Magnésio/metabolismo , Magnetismo , Sondas Moleculares/química , Sondas Moleculares/metabolismo , Nanopartículas , Compostos de Silício/síntese química , Compostos de Silício/metabolismo
3.
Artigo em Inglês | MEDLINE | ID: mdl-22506707

RESUMO

A magnesium-aluminum layered double hydroxide intercalated with NO(3)(-) (NO(3)•Mg-Al LDH) removed Sb(V) in solution. The antimony (Sb) removal increased with time and with an increasing molar ratio of Al/Sb, i.e., the quantity of NO(3)•Mg-Al LDH. The removal of Sb(V) in solution by NO(3)•Mg-Al LDH was not due to the reaction of Sb(V) with dissolved Mg(2+) but was rather caused by anion exchange between Sb(V), i.e., Sb(OH)(6)(-), in an aqueous solution and NO(3)(-) in the interlayer of the Mg-Al LDH. The intercalation of Sb(OH)(6)(-) in the interlayer of Mg-Al LDH is thought to result in the formation of a brandholzite-like structure. Some Sb(OH)(6) (-) was likely adsorbed on the surface of the NO(3)•Mg-Al LDH. The efficiency of the Sb removal decreased in the following order, irrespective of the reaction time: NO(3)•Mg-Al LDH ≈ Cl•Mg-Al LDH > SO(4)•Mg-Al LDH > CO(3)•Mg-Al LDH. The removal of Sb by SO(4)•Mg-Al LDH and Cl•Mg-Al LDH was also caused by anion exchange between Sb(V), i.e., Sb(OH)(6) (-), in an aqueous solution and SO(4)(2-) and Cl(-) in the interlayer of Mg-Al LDH, which formed a brandholzite-like structure due to the intercalation of Sb(OH)(6)(-) into the interlayer. In the case of SO(4)•Mg-Al LDH, hydrogen bonds between the Mg-Al LDH-positive host layer and Sb(OH)(6)(-) were probably stronger than the electrostatic force of attraction between the Mg-Al LDH-positive host layer and SO(4)(2-). The results suggested that Cl•Mg-Al LDH was as effective as NO(3)•Mg-Al LDH for the treatment of Sb(V) in aqueous solutions.


Assuntos
Alumínio/química , Resinas de Troca Aniônica , Antimônio/isolamento & purificação , Hidróxidos/síntese química , Compostos de Magnésio/síntese química , Magnésio/química , Cátions , Hidróxidos/química , Soluções , Água/química , Difração de Raios X
4.
AAPS PharmSciTech ; 12(2): 683-92, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21594728

RESUMO

Nicotine (NCT) buccal tablets consisting of sodium alginate (SA) and nicotine-magnesium aluminum silicate (NCT-MAS) complexes acting as drug carriers were prepared using the direct compression method. The effects of the preparation pH levels of the NCT-MAS complexes and the complex/SA ratios on NCT release, permeation across mucosa, and mucoadhesive properties of the tablets were investigated. The NCT-MAS complex-loaded SA tablets had good physical properties and zero-order release kinetics of NCT, which indicate a swelling/erosion-controlled release mechanism. Measurement of unidirectional NCT release and permeation across porcine esophageal mucosa using a modified USP dissolution apparatus 2 showed that NCT delivery was controlled by the swollen gel matrix of the tablets. This matrix, which controlled drug diffusion, resulted from the molecular interactions of SA and MAS. Tablets containing the NCT-MAS complexes prepared at pH 9 showed remarkably higher NCT permeation rates than those containing the complexes prepared at acidic and neutral pH levels. Larger amounts of SA in the tablets decreased NCT release and permeation rates. Additionally, the presence of SA could enhance the mucoadhesive properties of the tablets. These findings suggest that SA plays the important role not only in controlling release and permeation of NCT but also for enhancing the mucoadhesive properties of the NCT-MAS complex-loaded SA tablets, and these tablets demonstrate a promising buccal delivery system for NCT.


Assuntos
Alginatos/síntese química , Compostos de Alumínio/síntese química , Portadores de Fármacos/síntese química , Compostos de Magnésio/síntese química , Nicotina/síntese química , Silicatos/síntese química , Administração Bucal , Alginatos/administração & dosagem , Alginatos/farmacocinética , Compostos de Alumínio/administração & dosagem , Compostos de Alumínio/farmacocinética , Animais , Portadores de Fármacos/administração & dosagem , Portadores de Fármacos/farmacocinética , Sistemas de Liberação de Medicamentos/métodos , Sistemas de Liberação de Medicamentos/normas , Ácido Glucurônico/administração & dosagem , Ácido Glucurônico/síntese química , Ácido Glucurônico/farmacocinética , Ácidos Hexurônicos/administração & dosagem , Ácidos Hexurônicos/síntese química , Ácidos Hexurônicos/farmacocinética , Concentração de Íons de Hidrogênio , Compostos de Magnésio/administração & dosagem , Compostos de Magnésio/farmacocinética , Mucosa Bucal/efeitos dos fármacos , Mucosa Bucal/metabolismo , Nicotina/administração & dosagem , Nicotina/farmacocinética , Silicatos/administração & dosagem , Silicatos/farmacocinética , Suínos , Comprimidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA